Five biosimilars soon to be marketed in Canada!

We are very proud to announce the signature of an exclusive partenership agreement with Alvotech, a world-class biopharmaceutical company base in Reykjavik, Iceland, to soon market five biosimilar medecines for Canadian patients.

This historic agreement allows us to reaffirm our mission to improve access to affordable medicines for Canadian patients and to position ourselves as a major player in this market.

Press release
More information on biosimilars (Canada Health)